CLINICAL_TRIALS
trial_result
· 2020-10-20
Clinical Trial Update: Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port [NA]
Summary
A terminated safety study evaluating the combination of Symlin with insulin in patients using a multiple injection port; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Texas Diabetes & Endocrinology, P.A. | Conditions: Type 1 Diabetes, Type 2 Diabetes | NA | Status: TERMINATED | Results posted: 2020-10-20